Local Institution

South Brisbane, Queensland 4101

0 studies enrolling now · 14 studies all time

What they study most

Breast Cancer, Cancer, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Crohn's Disease, Dyslipidemia, Ependymoma, Ewing Sarcoma, High-grade Glioma, Leukemia and Lymphoma, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Lymphoma

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer — Stopped early
• An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) — Completed
• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
• Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML — Completed
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma — Completed
• Safety Study of BMS-770767 in Subjects With Hypercholesterolemia — Completed
• Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib — Completed
• Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia — Completed
• A Study of Abatacept in Patients With Active Crohn's Disease — Stopped early
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed